Member Info for Doc83

Hi Skippy,

I’ve just checked the Bloomberg terminal for daily volume over one month and the average daily traded is 1.57m shares. Halfway through today and 778,403 shares have been traded, so bang on the average I would say. Quite often we don’t break 1m shares volume.

Largest single day volume over last month was on 5/11 where 6.2m were traded. Smallest was just 264k on 24/11. Over 1yr, largest day volume was 14.3m on 30/4.

How do we watch the presentation later? The ESWI website only wants you to sign up for participation…

*market* sensitive information.

Hi TLWilliams, re your last paragraph on the presentation later today, I tend to agree. But I’m still a little confused as to why they RNS’d it… “matter sensitive information”?

A disgracefully wide spread again. Complete nonsense and these type of spreads are reserved for extremely low volume stocks. As Rajbury says, likely a stop loss raid.

Thought I’d check in to see if there were any new snippets of info I’d missed or stories/articles people might have seen in the Sunday news.

Instead, I think there might be a few bad hangovers on here! :)

Ouch, thanks SBM!

Where does it take you if P3 fails?!

I don’t see any TR1 landing. It looks like Polygon think they have enough now and a new investor coming in is all well and good, but if you think 5% of the company is 10 million shares, the volume traded over the last week or two just doesn’t support that.

I’ll be very happy to be proven wrong. Regardless, P3 outcome now very close.

Gunto, Andybe4’s original post at 3.02am (he/she obviously can’t sleep!) I maintain was a useful post. 25 other members obviously agree by recommending it.

I do agree that they flip and flop between being super positive and then super nervous. But I see many posters on here who spread worse nonsense. Those that can spot trading patterns and predict TR1’s (that still haven’t materialised!).

LTH’s who deserve to see SNG succeed will be fully aware of which posters they should and shouldn’t listen to.

I do think Andybe4 has been treated a bit harshly here. I wasn’t aware of Adagio Therapeutics but have now done some reading and it further highlights the potential prices SNG could achieve with a successful P3.
Adagio is yet another injection (that people will likely be sceptical about) and isn’t as far along in the development cycle as SNG, yet has a market cap getting on for 10x more.

You really do hear some nonsense on these BB’s…

Comforting to hear, Matml74.

I value your opinion on here, so would be interested in your own best guess if we might get news before end of December, or even perhaps 15th December?!

Infoking, you’ll know within a month or so… exciting and nerve wracking at the same time!

Tattyhead, I agree. You can see governments right now saying “we’ll lend you the money but want your drug for a song…”.

Purple1, the long term average P/E on the FTSE100 is only something like 15x. For a small, new company with one drug I think it would be prudent to base calculations on something as low as 4-8x earnings.

I also reckon the price SNG could charge will be some way below £2k per treatment. Where I think it could balance out is the number they manage to sell… I think demand will be there as it’s currently quite unique.

If I could see a year into the future, I wouldn’t be surprised to see the price anywhere between £0-100 per share! Obviously I’m well invested here so hope for a good outcome. My own prediction is £20-25 before we get taken out by big pharma. I can’t see any price less than £10 on a successful P3.

Hopefully Forrest Gump is invested here ;)

govck, I actually agree with most of what you are saying. I am hoping that typical timescales are thrown out of the window and, if successful, SNG’s drug is chivvied along a bit faster than usual. The market also seems to be even more forward looking than usual with Covid stocks.

My understanding was that all the ducks have been lined up (Aerogen, Thermo Fisher etc) and even supply chain issue with glass they have found a work around for, that production can be ramped up very quickly. Put it this way, if hypothetically SNG was so powerful it could save millions of lives, they’ll make sure it’s manufactured somehow.

Regardless and even if there are supply chain/production issues, the share price will go well north of £2.02 on a successful P3 outcome.

Strictly, market going better presumably because they think Omicron won’t be as bad as first thought. So obviously not good for Covid stocks. We know though that SNG or something like it will be needed regardless!